Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa.

Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, Bennett A, Verity R, Gething P, Roper C, Alifrangis M.

BMJ Glob Health. 2018 Oct 19;3(5):e000999. doi: 10.1136/bmjgh-2018-000999. eCollection 2018.

2.

Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.

Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP.

PLoS One. 2018 Feb 1;13(2):e0191922. doi: 10.1371/journal.pone.0191922. eCollection 2018.

3.

Habitat productivity and pyrethroid susceptibility status of Aedes aegypti mosquitoes in Dar es Salaam, Tanzania.

Mathias L, Baraka V, Philbert A, Innocent E, Francis F, Nkwengulila G, Kweka EJ.

Infect Dis Poverty. 2017 Jun 9;6(1):102. doi: 10.1186/s40249-017-0316-0.

4.

Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo.

Baraka V, Delgado-Ratto C, Nag S, Ishengoma DS, Madebe RA, Mavoko HM, Nabasumba C, Lutumba P, Alifrangis M, Van Geertruyden JP.

Int J Antimicrob Agents. 2017 Apr;49(4):456-464. doi: 10.1016/j.ijantimicag.2016.12.007. Epub 2017 Feb 22.

PMID:
28237831
5.

Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania.

Ishengoma DS, Kamugisha ML, Rutta AS, Kagaruki GB, Kilale AM, Kahwa A, Kamugisha E, Baraka V, Mandara CI, Materu GS, Massaga JJ, Magesa SM, Lemnge MM, Mboera LE.

BMC Health Serv Res. 2017 Jan 23;17(1):70. doi: 10.1186/s12913-017-2030-9.

6.

Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania.

Mshana HJ, Baraka V, Misinzo G, Makunde WH.

J Trop Med. 2016;2016:7408187. doi: 10.1155/2016/7408187. Epub 2016 Dec 6.

7.

Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.

Mavoko HM, Nabasumba C, da Luz RI, Tinto H, D'Alessandro U, Kambugu A, Baraka V, Rosanas-Urgell A, Lutumba P, Van Geertruyden JP.

Lancet Glob Health. 2017 Jan;5(1):e60-e68. doi: 10.1016/S2214-109X(16)30236-4. Epub 2016 Nov 11.

8.

The Threat of Zika Virus in Sub-Saharan Africa - The Need to Remain Vigilant.

Baraka V, Kweka EJ.

Front Public Health. 2016 May 31;4:110. doi: 10.3389/fpubh.2016.00110. eCollection 2016. No abstract available.

9.

Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.

Poirot E, Vittinghoff E, Ishengoma D, Alifrangis M, Carneiro I, Hashim R, Baraka V, Mosha J, Gesase S, Chandramohan D, Gosling R.

PLoS One. 2015 Nov 23;10(11):e0142414. doi: 10.1371/journal.pone.0142414. eCollection 2015.

10.

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.

Baraka V, Ishengoma DS, Fransis F, Minja DT, Madebe RA, Ngatunga D, Van Geertruyden JP.

Malar J. 2015 Nov 5;14:439. doi: 10.1186/s12936-015-0977-8.

11.

Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania.

Golassa L, Kamugisha E, Ishengoma DS, Baraka V, Shayo A, Baliraine FN, Enweji N, Erko B, Aseffa A, Choy A, Swedberg G.

Malar J. 2015 Jul 8;14:264. doi: 10.1186/s12936-015-0783-3.

12.

The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania.

Mboera LE, Ishengoma DS, Kilale AM, Massawe IS, Rutta AS, Kagaruki GB, Kamugisha E, Baraka V, Mandara CI, Materu GS, Magesa SM.

BMC Health Serv Res. 2015 Jun 26;15:248. doi: 10.1186/s12913-015-0923-z.

13.

In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.

Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, Mbonye MK, Van Overmeir C, Rosanas-Urgell A, Van Geertruyden JP, D'Alessandro U, Erhart A.

Antimicrob Agents Chemother. 2015 Jan;59(1):734-7. doi: 10.1128/AAC.03647-14. Epub 2014 Nov 17.

14.

Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children.

Lavstsen T, Turner L, Saguti F, Magistrado P, Rask TS, Jespersen JS, Wang CW, Berger SS, Baraka V, Marquard AM, Seguin-Orlando A, Willerslev E, Gilbert MT, Lusingu J, Theander TG.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1791-800. doi: 10.1073/pnas.1120455109. Epub 2012 May 22.

Supplemental Content

Loading ...
Support Center